UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
under
the Securities Exchange Act of 1934
For
the month of: April 2026
Commission
file number: 001-36578
ENLIVEX
LTD.
(Translation
of registrant’s name into English)
14
Einstein Street, Nes Ziona, Israel 7403618
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
On
April 8, 2026, Enlivex Ltd., a company organized under
the laws of the State of Israel (“Enlivex”), issued a press release announcing that
Ondo Finance (“Ondo”) has launched ENLVon, the Ondo tokenized representation of Enlivex’s ordinary shares on Ondo’s
Global Markets platform. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
| Exhibit
No. |
|
|
| |
|
|
| 99.1 |
|
Press Release |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
Enlivex
Ltd. |
| |
(Registrant) |
| |
|
| |
By: |
/s/
Oren Hershkovitz |
| |
Name:
Title: |
Oren
Hershkovitz
Chief Executive Officer |
Date:
April 8, 2026
Exhibit 99.1

Ondo Global Markets Tokenizes Enlivex’s
Ordinary Shares
Nes-Ziona, Israel, April 08, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd.
(Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury,
today announced that Ondo Finance (“Ondo”) has launched ENLVon, the Ondo tokenized representation of ENLV’s ordinary
shares on Ondo’s Global Markets platform.
Through the launch of ENLVon, non-U.S. retail
and institutional investors can gain direct economic exposure to Enlivex’s ordinary shares through digital infrastructure, without
needing a traditional brokerage account. ENLVon can be held in a compatible digital wallet, transferred subject to applicable platform
and regulatory requirements, and may be integrated into a growing ecosystem of financial applications, including use as collateral or
within lending and yield-generating strategies. The model also enables fractional exposure with low minimum investment amounts and near-instant
settlement.
The
tokenized stock market has recently surpassed $1 billion in on-chain value1,
highlighting the rapid growth of this emerging asset class and its potential to broaden access to traditional securities for investors
globally. Within this market, Ondo has established itself as the leading platform, with more than 61% market share and approximately
$653 million in tokenized stock value, while supporting roughly 265 tokenized securities and ETFs across major blockchain networks including
Ethereum, BNB Chain, and Solana2.
Oren Hershkovitz, Chief Executive Officer of Enlivex,
stated, “We view the tokenization of Enlivex on Ondo Global Markets as an extension of our efforts to align the Company with innovation
at the intersection of capital markets and blockchain infrastructure. ENLVon expands accessibility to a global base of digitally native
investors who understand what we are building: the only Nasdaq-listed company operating a prediction markets treasury alongside a clinical-stage
quality longevity program.”
About Enlivex (Nasdaq: ENLV)
Enlivex is a quality longevity company powered
by a prediction markets treasury. The Company is advancing Allocetra™, an advanced clinical-stage immunotherapy targeting inflammatory
conditions associated with aging, with a primary focus on age-related osteoarthritis.
In addition to its clinical programs, Enlivex
operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure
on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets
ecosystem.
Forward-Looking Statements
This press release contains forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements include statements relating to the anticipated benefits of the Company’s tokenization
strategy; the potential impact of ENLVon’s availability through Ondo Global Markets on investor access, market visibility, and trading
flexibility; market size and growth opportunities in tokenized securities; regulatory and technological developments relating to digital
assets and tokenized equities; and the Company’s broader business strategy, clinical development programs, financial condition,
and future performance.
Each forward-looking statement contained in this
press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied
by such statement. Applicable risks and uncertainties include, among others, the risk that tokenization of the Company’s equity
does not lead to increased liquidity, trading activity, or investor interest; risks associated with digital asset exchanges, custodians,
trading venues, and market infrastructure; legal, tax, commercial, and regulatory uncertainty regarding tokenized securities and digital
assets; changes in market, business, financial, or geopolitical conditions; and those risks and uncertainties identified in the Company’s
filings with the Securities and Exchange Commission.
The forward-looking statements in this press release
speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements, except
as required by applicable law.
ENLIVEX CONTACT
Shachar Shlosberger, CFO
Enlivex Ltd.
shachar@enlivex.com
| 1 | Crypto.com DeFi Weekly (March
18, 2026) |
| 2 | AInvest (March 28, 2026) |